Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
261.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (1.154%)
Market Cap: £237.55m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Update

2 Sep 2015 09:05

RNS Number : 7570X
Concurrent Technologies PLC
02 September 2015
 

02 September 2015

Concurrent Technologies Plc

 

Product Update

Next generation 3U VPXTM board featuring newly launched processor

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce the launch of their first single board computer, a TR E5x/msd, based on the new Intel® Xeon® processor E3 family.

 

The TR E5x/msd features a quad core Intel® Xeon® processor with up to 16 Gbytes of DRAM and a rich assortment of I/O interfaces. With further improved processing and graphics performance and a wider range of configuration options than previous products, the TR E5x/msd is particularly suited to high-end multi-processor applications such as Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance applications within the defence market which is an important contributor to the Company's revenues. The product is expected to appeal to both existing and new customers within the defence market as well as the aerospace and transportation markets.

 

Initial shipments of air-cooled variants will be followed by rugged conduction-cooled modules, once the necessary qualifications are complete, ensuring this product will appeal to applications within both benign and harsh environments.

 

Glen Fawcett, CEO, Concurrent Technologies Plc, commented:

"We are excited to introduce our first new generation Intel® Xeon® processor based board. We are committed to delivering high quality embedded computers utilising the latest processors from Intel to advance our Size, Weight and Power (SWAP) propositions. The VPX form-factor is a popular choice and the new board complements our existing range of processor boards, switches, mass storage, I/O expansion carriers and development systems to provide a straightforward path from prototype to deployment."

 

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

Newgate (Financial PR)Tim Thompson

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

Nick Tulloch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using mainly Intel® processors, including the latest generation Intel® Core™ i7 processors, Intel® Xeon® and Intel® Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments. Other processors now include NVIDIA® Tegra® K1 devices.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLBMATMBTMBAA
Date   Source Headline
19th Mar 201412:36 pmRNSNotice of Results
17th Feb 20144:18 pmRNSHolding(s) in Company
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.